jsonify-logo-light Designer: Matt Farley Open in Jsonify

I want to get continuous structured data on new clinical trial protocols, regulatory submission requirements, and outcome measures from global research registers, regulatory body websites, and academic publications.

Access real-time insights on clinical trials and regulations — streamlined automation replaces tedious manual searches

A saved example of what you can collect and monitor with Jsonify. Create your own version in Jsonify.

Build this in JsonifyYour original goal is prefilled.

Goal

I want to get continuous structured data on new clinical trial protocols, regulatory submission requirements, and outcome measures from global research registers, regulatory body websites, and academic publications.

Source coverage

Sample data

Illustrative sample data from the original configuration, not live or verified results.

idSourceTrialIDTitlePhaseInterventionPrimaryOutcomeStartDateLastUpdatedStatusLocationSampleSize
1clinicaltrials.govNCT05812345Randomized Phase 2 Trial of ABX-201 vs Placebo in Treatment-Naïve Moderate COVID-25Phase 2ABX-201 oral 200 mg dailyChange in WHO Clinical Progression Scale at Day 142026-01-152026-02-02RecruitingUnited States, Canada240
2ema.europa.euEUCTR2026-000123-45Open-label Phase 3 Study of OncoVax-P in HER2-negative Metastatic Breast CancerPhase 3OncoVax-P IV every 3 weeks + standard chemoProgression-free survival at 12 months2025-12-012026-02-03Active, not recruitingGermany, France, Spain640
3who.intWHO-ITH-2026-001Cluster RCT of Community-based Malaria Prophylaxis in Rural UgandaPhase 4Monthly DP (dihydroartemisinin–piperaquine) sachetsIncidence of symptomatic malaria episodes per 1000 person-years2025-11-202026-02-01OngoingUganda4800
4clinicaltrialsregister.euCTR2026-78901Phase 1/2 Study of Lenti-CRISPR Therapy for Sickle Cell DiseasePhase 1/2Ex vivo Lenti-CRISPR autologous infusionPercentage of patients with hemoglobin >9 g/dL at 6 months2025-12-102026-02-04RecruitingUnited Kingdom, Netherlands48
5gov.ukMHRA-CT-2026-012Randomized Controlled Trial of RSV Vaccine NVX-RSV in Adults ≥60Phase 3NVX-RSV single IM dose vs placeboVaccine efficacy against laboratory-confirmed RSV LRTI at 6 months2025-12-182026-02-03RecruitingUnited Kingdom12000
6alltrials.netAT-TRIAL-2026-77Comparative Effectiveness of Telemedicine Behavioral Therapy for Opioid Use DisorderPhase 3Weekly telemedicine CBT vs in-person CBTRetention in treatment at 24 weeks2025-12-052026-02-02Active, not recruitingUnited States900
7researchgate.netRG-2026-PRO-09Pilot Trial of Novel Inhaled Insulin Formulation in Type 1 DiabetesPhase 1Inhaled insulin micro‑aerosol, dose-escalationSafety: rate of hypoglycemia episodes within 28 days2026-01-202026-02-04RecruitingAustralia36
8thelancet.comTLC-CLIN-2026-02Multicentre Trial of High-dose IV Vitamin C in Severe SepsisPhase 3IV Vitamin C 6 g q6h for 4 days + standard care28-day all-cause mortality2025-11-302026-02-01OngoingMulti-country (UK, India, Brazil)1500
9academic.oup.comOUP-TR-2026-11Randomized Study of Omega-3 Supplementation for Prevention of Postoperative Atrial FibrillationPhase 4Omega-3 2 g daily vs placebo for 30 daysIncidence of AF within 30 days post-cardiac surgery2025-12-222026-02-03RecruitingUnited States1200
10sciencedirect.comSD-RES-2026-334Phase 2 Trial of Oral TYK2 Inhibitor for Moderate-to-Severe PsoriasisPhase 2TYK2 inhibitor 10 mg dailyPercent achieving PASI75 at Week 122026-01-102026-02-02RecruitingBrazil, Mexico240
11biomedcentral.comBMC-CLIN-2026-05Double-blind Trial of Probiotic Regimen to Prevent Antibiotic-associated Diarrhea in ElderlyPhase 4Multi-strain probiotic BID during antibioticsIncidence of AAD within 30 days2025-12-282026-02-04RecruitingUnited Kingdom800
12clinicaltrials.govNCT05900111Adaptive Platform Trial of Broad-spectrum Antivirals for Emerging Respiratory VirusesPhase 2/3Arm A: Broad-spectrum antiviral X; Arm B: Standard careTime to sustained clinical recovery (7-day symptom-free)2026-01-252026-02-03RecruitingGlobal (US, UK, India, South Africa)2400
13nctu.hsc.wvu.eduWVU-NCTU-2026-09Feasibility Study of Wearable ECG Monitoring to Detect Postoperative AFPhase 2Wearable continuous ECG patch vs standard telemetryDetection rate of AF within 7 days post-op2026-01-122026-02-01OngoingUnited States300
14clinicaltrialsregister.euCTR2026-99800Phase 2b Study of Oral GLP-1 Receptor Agonist in Nonalcoholic Steatohepatitis (NASH)Phase 2bGLP-1 RA 5 mg SC weekly vs placeboChange in liver fat fraction by MRI at 24 weeks2025-12-152026-02-04RecruitingItaly, Spain420
15gov.ukMHRA-CT-2026-033Randomized Trial of Short-course Antibiotics for Uncomplicated UTIs in WomenPhase 33-day vs 7-day antibiotic regimen (nitrofurantoin)Clinical cure at Day 142026-01-052026-02-02RecruitingUnited Kingdom1500
16who.intWHO-VAX-2026-012Phase 2 Study of Novel Dengue Vaccine Candidate in AdolescentsPhase 2Dengue tetravalent recombinant vaccine, 2 doses IMNeutralizing antibody GMT at Day 562025-12-022026-02-03Active, not recruitingIndonesia, Philippines900
17thelan cet.comTLC-ONC-2026-08Neoadjuvant Immunotherapy with Anti-PD-1 + Chemo in Triple-negative Breast CancerPhase 2Anti-PD-1 IV q3w x4 + standard chemoPathologic complete response rate at surgery2025-12-072026-02-01RecruitingUnited States, Canada, UK180
18researchgate.netRG-2026-ENDO-21Randomized Trial of Low-dose Estradiol Vaginal Ring for Genitourinary Syndrome of MenopausePhase 3Estradiol ring 12-week vs placeboChange in GSM symptom score at 12 weeks2026-01-182026-02-04RecruitingGermany, Sweden480
19academic.oup.comOUP-DERM-2026-03Topical Small-molecule JAK Inhibitor Cream for Atopic DermatitisPhase 2JAK inhibitor 2% cream BID vs vehicleEASI score reduction at Week 82026-01-082026-02-02RecruitingUnited States, Canada300
20sciencedirect.comSD-NEURO-2026-17Phase 3 Trial of Subcutaneous Anti-Tau Antibody in Early Alzheimer's DiseasePhase 3Anti-Tau mAb 600 mg SC q4wChange in CDR-SB at 18 months2025-11-252026-02-03Active, not recruitingUnited States, Japan, South Korea2600
21biomedcentral.comBMC-PSY-2026-02Digital CBT App vs Waitlist for Adolescent Anxiety: Pragmatic TrialPhase 3Digital CBT app access for 12 weeksChange in GAD-7 score at 12 weeks2026-01-222026-02-04RecruitingUnited Kingdom1200
22clinicaltrials.govNCT05890077Dose-ranging Phase 1 Study of Novel Anticoagulant FXIa InhibitorPhase 1FXIa inhibitor oral tablets, single ascending dosesDose-limiting adverse events within 28 days2026-01-302026-02-04RecruitingUnited States72
23clinicaltrialsregister.euCTR2026-45012Randomized Study of Early Mobilization Protocol After Hip Fracture RepairPhase 4Enhanced mobilization protocol vs standard physiotherapyTime to independent ambulation within 30 days2025-12-202026-02-02OngoingSweden, Norway560
24gov.ukMHRA-CT-2026-078Vaccine Immunogenicity Study of Seasonal Influenza Formulation in Healthcare WorkersPhase 4Quadrivalent influenza vaccine annual doseSeroconversion rate at Day 282026-01-102026-02-01RecruitingUnited Kingdom2000
25who.intWHO-PRT-2026-005Water, Sanitation and Hygiene (WASH) Intervention Trial to Reduce Childhood DiarrheaPhase 4Community WASH package vs standard practiceIncidence rate of diarrheal episodes in children <5 over 12 months2025-12-052026-02-03OngoingBangladesh7200
26alltrials.netAT-ONC-2026-19Registry-linked Trial of CAR-T Toxicity Mitigation StrategiesPhase 2Early IL-6 blockade protocol vs standard supportive careIncidence of Grade ≥3 cytokine release syndrome within 30 days2026-01-142026-02-04RecruitingUnited States360
27researchgate.netRG-IMMU-2026-14First-in-Human Study of Intranasal Monoclonal Antibody for Seasonal AllergyPhase 1Intranasal mAb spray, single dose cohortLocal tolerability and symptom scores at 7 days2026-01-052026-02-02RecruitingCanada48
28thelancet.comTLC-INF-2026-06Cluster Randomized Trial of Antibiotic Stewardship in Neonatal UnitsPhase 3Stewardship bundle vs usual careAntibiotic days per 1000 patient-days over 6 months2025-11-282026-02-01OngoingSouth Africa, Kenya4200
29academic.oup.comOUP-CARD-2026-07Randomized Trial of Remote Ischemic Conditioning to Reduce Myocardial InjuryPhase 2RIPC device perioperative vs shamTroponin rise >5x baseline within 48 hours2026-01-022026-02-03RecruitingUnited Kingdom540
30sciencedirect.comSD-ENDO-2026-29Phase 2 Trial of Oral SGLT3 Inhibitor in Diabetic Kidney DiseasePhase 2SGLT3 inhibitor 10 mg dailyChange in eGFR slope at 52 weeks2025-12-122026-02-04Active, not recruitingUnited States, Canada, Australia600

Insights and analytics

Change notifications

Integrations and delivery

Make this your own

Start with this goal in Jsonify, then choose the sources and data you need.

Build this in Jsonify